Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa

Carlo Alberto Vignolia Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy;b Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, ItalyCorrespondence[email protected]

https://orcid.org/0000-0003-0452-8710 View further author information

Luigi Gargiuloa Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy;b Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, ItalyView further author information

Federica Sannab Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, ItalyView further author information

Alessandra Narcisib Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, ItalyView further author information

Antonio Costanzoa Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy;b Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, ItalyView further author information

References

Camela E, Potestio L, Fabbrocini G, et al. Paradoxical reactions to biologicals for psoriasis. Expert Opin Biol Ther. 2022;22(12):1–3. doi:10.1080/14712598.2022.2153593.
PubMed Web of Science ®Google Scholar
Miyagawa F. Pathogenesis of paradoxical reactions associated with targeted biologic agents for inflammatory skin diseases. Biomedicines. 2022;10(7):1485. doi:10.3390/biomedicines10071485.
PubMed Web of Science ®Google Scholar
Murphy MJ, Cohen JM, Vesely MD, et al. Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis. J Am Acad Dermatol. 2022;86(5):1080–1091. doi:10.1016/j.jaad.2020.12.010.
PubMed Web of Science ®Google Scholar
Griffiths CE, Reich K, Lebwohl M, et al. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet. 2015;386(9993):541–551. doi:10.1016/S0140-6736(15)60125-8.
PubMed Web of Science ®Google Scholar
Puig L, Gulliver W. Adverse reactions to biologics. In: Puig L, Gulliver W, editors. Adverse reactions to biologics. Current problems in dermatology. Vol. 53. Basel: Karger; 2018. p. 49–63.
Google Scholar
Palucka AK, Blanck J-P, Bennett L, et al. Cross-regulation of TNF and IFN-α in autoimmune diseases. Proc Natl Acad Sci USA. 2005;102(9):3372–3377. doi:10.1073/pnas.0408506102.
PubMed Web of Science ®Google Scholar

Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date